Kangmei Pharmaceutical Market Cap

Kangmei Pharmaceutical has a market cap or net worth of 25.86 billion as of March 9, 2026. Its market cap has decreased by -18.55% in one year.

Market Cap

25.86B

Enterprise Value

24.84B

Revenue

5.28B

Ranking

n/a

PE Ratio

1,554.05

Stock Price

1.87

Market Cap Chart

Since March 19, 2001, Kangmei Pharmaceutical's market cap has increased from 2.58B to 25.86B, an increase of 902.90%. That is a compound annual growth rate of 9.67%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	26.00B	-1.57%
Dec 31, 2025	26.41B	-18.58%
Dec 31, 2024	32.44B	25.81%
Dec 29, 2023	25.79B	-15.45%
Dec 30, 2022	30.50B	-28.80%
Dec 31, 2021	42.84B	221.38%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Chengdu Kanghong Pharmaceutical Group	25.74B
Hubei Jumpcan Pharmaceutical	25.57B
Livzon Pharmaceutical Group	27.97B
Shijiazhuang Yiling Pharmaceutical	28.00B
Zhejiang Huahai Pharmaceutical	23.83B
Tianjin Pharmaceutical Da Ren Tang Group Corporation	28.41B
Dizal (Jiangsu) Pharmaceutical	23.58B
Jiangsu Nhwa Pharmaceutical Co., LTD	23.57B

Market Cap Rankings